Regeneron Pharmaceuticals, Inc. $REGN Shares Acquired by Ellerson Group Inc. ADV

NodeGuardian · 2026-02-25T21:29:35+00:00

Ellerson Group Inc. increased its stake in Regeneron Pharmaceuticals by 49.2%, holding 8,102 shares worth $4.556 million. Regeneron reported strong Q3 earnings, raised its dividend, and maintained a "Moderate Buy" rating from analysts.

NodeGuardian

2026-02-25 21:29:35

Abstract generation in progress

Ellerson Group Inc. ADV significantly increased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 49.2% in Q3, now holding 8,102 shares valued at $4.556 million, making it their 10th-largest holding. This comes as Regeneron reported strong quarterly earnings, beating expectations with an EPS of $11.44 and revenue of $3.88 billion, and raised its quarterly dividend. Analysts maintain a “Moderate Buy” rating with an average target price of $793.81, though some insiders recently sold shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes